Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis

被引:39
作者
Bäckman, ML
Santavuori, PR
Åberg, LE
Aronen, ET
机构
[1] Univ Helsinki, Dept Pediat Neurol, Hosp Children & Adolescents, Helsinki, Finland
[2] Univ Helsinki, Dept Psychiat, Hosp Children & Adolescents, SF-00180 Helsinki, Finland
关键词
JNCL; neurological disorder; psychiatric symptoms;
D O I
10.1111/j.1365-2788.2005.00659.x
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
Background Juvenile neuronal ceroid lipofuscinosis (JNCL) is one of the most common neurodegenerative disorders in childhood and adolescence. The clinical picture includes diverse and complex psychiatric symptoms that are difficult to treat. Only symptomatic treatment is available. To improve symptomatic therapy, it is important to recognize the symptoms. The purpose of this study was to identify predominant psychiatric symptoms in patients with JNCL. Methods The study included 27 patients with JNCL with and without psychotropic treatment. The mean age was 15.2 (range 9-21) years. Characteristic psychiatric symptoms in this patient group were clarified by using the following standardized questionnaires filled in by parents, teachers and the patients themselves: Child Behavior Checklist (CBCL), Teacher Report Form (TRF) and Children's Depression Inventory (CDI). The symptoms were recorded for the entire study group and compared between patients with and without psychotropic treatment and between genders. Results The patients had a large number of psychiatric symptoms according to the CBCL and TRF. The most commonly reported symptoms were social, thought, attention problems, somatic complaints and aggressive behaviour. Patients receiving psychotropic medication had more psychiatric symptoms according to the CBCL and TRF. Moreover, female patients had more problems than male patients according to the CBCL. The total psychiatric symptom score was at clinical or borderline range for psychiatric disturbance in 74% of patients. The number of depressive symptoms reported by the patients themselves was low. Conclusions JNCL patients suffer from a multitude of psychiatric symptoms. To improve drug choice and dosage, a thorough evaluation of these symptoms by standardized methods is needed before initiating treatment. Progress and possible adverse effects of treatment should be monitored on a regular basis.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 25 条
[1]  
Aberg Laura E, 2002, Eur J Paediatr Neurol, V6, P199, DOI 10.1053/ejpn.2002.0594
[2]   Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis [J].
Åberg, LE ;
Bäckman, M ;
Kirveskari, E ;
Santavuori, P .
EPILEPSIA, 2000, 41 (10) :1296-1302
[3]  
ACHENBACH TM, 2001, INTEGRATIVE GUIDE 19
[4]   Sleep and psychiatric symptoms in school-age children [J].
Aronen, ET ;
Paavonen, EJ ;
Fjällberg, M ;
Soininen, M ;
Törrönen, J .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2000, 39 (04) :502-508
[5]  
Backman M L, 2001, Eur J Paediatr Neurol, V5 Suppl A, P163, DOI 10.1053/ejpn.2000.0455
[6]   BEHAVIOR IN MUCOPOLYSACCHARIDE DISORDERS [J].
BAX, MCO ;
COLVILLE, GA .
ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (01) :77-81
[7]  
Besag FMC, 1998, J INTELL DISABIL RES, V42, P50
[8]   NEUROLOGY OF THE NEURONAL CEROID-LIPOFUSCINOSES - LATE INFANTILE AND JUVENILE TYPES [J].
BOUSTANY, RM .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 42 (04) :533-535
[9]   SEIZURES, DEPRESSION AND DEMENTIA IN TEENAGERS WITH BATTEN-DISEASE [J].
BOUSTANY, RM ;
FILIPEK, P .
JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (02) :252-255
[10]   BATTEN DISEASE (SPIELMEYER-VOGT DISEASE, JUVENILE ONSET NEURONAL CEROID-LIPOFUSCINOSIS) GENE (CLN3) MAPS TO HUMAN CHROMOSOME-16 [J].
GARDINER, M ;
SANDFORD, A ;
DEADMAN, M ;
POULTON, J ;
COOKSON, W ;
REEDERS, S ;
JOKIAHO, I ;
PELTONEN, L ;
EIBERG, H ;
JULIER, C .
GENOMICS, 1990, 8 (02) :387-390